# Emergent BioSolutions signs $65M contract to supply NARCAN Nasal Spray to Ontario Ministry of Health

Emergent BioSolutions signed a three-year agreement valued at approximately $65 million to supply NARCAN Nasal Spray to the Ontario Ministry of Health for the Ontario Naloxone Program, supporting opioid overdose prevention.

- Type: Contract
- Announced: 2025-05-01
- Where: Ontario, Canada
- Value: $65.0M
- Status: announced
- Products: NARCAN Nasal Spray (naloxone)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Emergent BioSolutions](https://endata.com/companies/34613.md) (supplier)
- [Ontario Ministry of Health](https://endata.com/companies/84499.md) (customer)

## Sources

- [quiverquant.com](https://www.quiverquant.com/news/Emergent+BioSolutions+Secures+%2465+Million+Agreement+to+Supply+NARCAN%C2%AE+Nasal+Spray+to+Ontario+Ministry+of+Health), 2025-05-01: "Emergent BioSolutions signed a $65 million contract to supply NARCAN® Nasal Spray to Ontario's Naloxone Program for opioid overdose prevention."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.